Go to content

Suramin hexasodium salt, gr. 1, CAS 129-46-4 - https://www.eurchem.net

Skip menu
chemical engineering for innovative research
Skip menu
technical file
:
C.O.A.
product name
product origin
purity grade
use
product code
C.A.S. number
MDL
EINECS
ID PubChem
NACRES
molecular formula
lmolecular weight
assay (HPLC)
quality level
storage & sensitivity
solubility
appearance (color)
form
description
x
x
















note (1)
note (2)

packaging/transport
standardization
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
Suramin hexasodium salt, ACS - sterilized
100% made in European Union *(according to USP, EUP, Echa-Reach)
>99.99% (raw matter, ultra-pure, selected)
lab. / tech. / pharmaceutical / bio-research / dietary supplement
EA61707
129-46-4
MFCD00210217
204-949-3
24277738
NA.25
C
51H34N6Na6O23S6
1429.16
>99.99%  to <101.5%
200
Store in cool place; keep container tightly closed in a dry and well-ventilated place (5 °C to 25 °C).
Soluble in water and saline (turbidity) <15% (H2O >10 mg/mL); sparingly soluble in 95% bethanol .
white to pale cream                             
powder
Suramin is an antiparasitic drug , which blocks endothelial cell proliferation and increases tyrosine phosphorylation of many signalling proteins; associated with urticaria, paresthesias, vomitino  and
neurologic toxicity; Suramin is used to treat trypanosomiasis and onchocerciasis; it functions as an heparanase inhibitor and also exhibits anti-AIDS (acquired immunodeficiency syndrome) property. Suramin sodium salt has been used:
- as a potent blocker of rat P2Y2 purinergic receptor
- to study its effects on short circuit current (Isc) across strial marginal cells
- to show its effects on initial burst of glial activity
- to assess its neuroprotective potential in rats
- as a purinoceptor inhibitor, to explore the mechanism of action of extracellular adenosine triphosphate (eATP) .
Suramin Sodium has been observed as a potent inhibitor of melanoma HPA (heparanase)  and tumor cell metastasis. Inhibition of NAD+-dependent deacetylase SIRT1 with an IC50 of 2.6 ?M along with SIRT5 has also been observed ; Suramin Sodium has been recorded  to antagonize EDG-3 (S1P3) selectively. Suramin Sodium is an inhibitor of A cyclase , FGF-1, FGF-2, IL-1, IL-4, PDGF, PC-PLD, PKC, SH-PTP, TERT, TGF beta 1, Topo I, Topo II and VEGF ; it  is  used as a  G protein uncoupler and inhibitor of PDGF, EGF, TGF-β, SIRT1 and SIRT5 ;
it also blocks calmodulin binding to recognition sites and G protein coupling to G protein-coupled receptors; increases open probability of ryanodine receptor (RyR) channels ; anticancer and antiviral agent .
Store in cool place ; keep container tightly closed in a dry and well-ventilated place *(1) ;
keep away from strong oxidizing agents *(1) .
2 (two) years from production date (sealed package) ,  * shipped in ambient (1) .                             
This product is for research use only, is not to be used for therapeutic; not intended for animal or human or diagnostic or therapeutic use , and cannot be sold to patients.
Special for chemical transport (according to IATA / ADR / ECHA-REACH rules / int.l laws)
According to U.S. / E.U. Pharmacopoeia, Echa-Reach, UNI EN ISO 14001, G.M.P., M.S.D.S., etc...
Price without discount€ 1250.00
*
possible additional
 discount for large
quantity orders


     pharmaceutical  and chemicals Division
Bangarten, 21/15 - Vaduz (Liechtenstein) LI9490
exclusive dealer for Europe :
Eurchem
copyright ©®™ 2025





_________________________________________________________________________________________________________________________________________________________________


Back to content